AlloVir (NASDAQ:ALVR) Stock Price Down 1.2% – Time to Sell?

AlloVir, Inc. (NASDAQ:ALVR)’s stock price dropped 1.2% during trading on Wednesday . The stock traded as low as $0.49 and last traded at $0.51. Approximately 460,323 shares changed hands during mid-day trading, a decline of 23% from the average daily volume of 600,335 shares. The stock had previously closed at $0.51.

AlloVir Stock Down 2.2 %

The firm has a market cap of $52.01 million, a PE ratio of -0.51 and a beta of 0.59. The business has a 50-day moving average price of $0.69 and a two-hundred day moving average price of $0.74.

AlloVir (NASDAQ:ALVR) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.10.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Cubist Systematic Strategies LLC lifted its position in shares of AlloVir by 152.3% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 49,816 shares of the company’s stock worth $36,000 after purchasing an additional 30,072 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in AlloVir in the second quarter valued at $55,000. Finally, Price T Rowe Associates Inc. MD lifted its holdings in AlloVir by 127.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 97,986 shares of the company’s stock worth $74,000 after buying an additional 54,900 shares during the last quarter. Hedge funds and other institutional investors own 66.05% of the company’s stock.

AlloVir Company Profile

Allovir, Inc, a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus.